Due to the special nature of medicines, returns and exchanges are not supported.

Final delivery from the nearest overseas warehous NEW

Gefitinib

The FDA approved gefitinib for non-small cell lung cancer (NSCLC) in May 2003. It is approved as monotherapy for the treatment of patients with locally advanced or metastatic NSCLC after failure of platinum and docetaxel chemotherapy.

Categories: Oncology drugs, respiratory/skeleton system

Share:

Our offers

Saving your money for next purchases

Delivery – when you want and anywhere

A huge selection of best products

Health Classification

Let us work together to protect precious health

More